Overview

Freeze-Dried Black Raspberries in Preventing Oral Cancer Recurrence in High-Risk Appalachian Patients Previously Treated With Surgery For Oral Cancer

Status:
Active, not recruiting
Trial end date:
0000-00-00
Target enrollment:
44
Participant gender:
Both
Summary
This pilot clinical trial studies freeze-dried black raspberries in preventing oral cancer recurrence in high-risk Appalachian patients previously treated with surgery for oral cancer. Chemoprevention is the use of certain drugs to keep cancer from forming. Giving freeze-dried black raspberries may prevent oral cancer from forming
Phase:
N/A
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Ohio State University Comprehensive Cancer Center
Last Updated:
2015-12-15
Criteria
Inclusion Criteria:

- Patients from any Appalachian County with previously diagnosed, biopsy-proven,
surgically resected, oral squamous cell carcinoma (SCC) (stages T1 to T4), which
encompasses cancers of the oral cavity including lips, buccal mucosa, teeth, floor of
the mouth and gums and those of the oropharynx consisting of the base of the tongue,
soft palate, tonsillar area, and the posterior pharyngeal wall will be eligible

- Patients who have followed the advice of their physician and have been definitively
treated for their tumor by any method and are currently disease free will be eligible

- Patients may be enrolled as early as their first follow-up post-operative clinic
visit after their most recent surgery, but no more than 36 months post-surgery

- Patients must be able to take nutrition/medications orally

- No prior history of intolerance or allergy to berry or berry-containing products

Exclusion Criteria:

- History of intolerance (including hypersensitivity or allergy) to berry or
berry-containing products

- Patients who are actively receiving adjuvant therapy (radiation, chemotherapy) will
be excluded until such time as they have completed treatments

- Pregnant women; although there are no known adverse effects of black raspberries upon
the fetus, if patients become pregnant during period of LBR administration, then LBR
will be discontinued and patient will be removed from the study

- Inability to grant informed consent